Humana Inc
HUM259.340USD
-1.330-0.51%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
31.19BMarket Cap
24.19P/E TTM
More Details of Humana Inc Company
Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
Humana Inc Info
Ticker SymbolHUM
Company nameHumana Inc
IPO dateMay 18, 1971
CEORechtin (James A)
Number of employees65680
Security typeOrdinary Share
Fiscal year-endMay 18
Address500 W Main St
CityLOUISVILLE
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code40202
Phone15025801000
Websitehttps://www.humana.com/
Ticker SymbolHUM
IPO dateMay 18, 1971
CEORechtin (James A)
Company Executives of Humana Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
20.63K
--
Mr. Kurt J. Hilzinger
Mr. Kurt J. Hilzinger
Independent Chairman of the Board
Independent Chairman of the Board
19.45K
--
Mr. Joseph Christopher (Joe) Ventura
Mr. Joseph Christopher (Joe) Ventura
Chief Legal Officer
Chief Legal Officer
17.32K
+48.83%
Dr. Vishal Agrawal, M.D.
Dr. Vishal Agrawal, M.D.
Chief Strategy and Corporate Development Officer
Chief Strategy and Corporate Development Officer
16.72K
+35.01%
Mr. Jorge S. Mesquita
Mr. Jorge S. Mesquita
Independent Director
Independent Director
2.58K
+55.96%
Mr. John W. Garratt
Mr. John W. Garratt
Independent Director
Independent Director
1.69K
+34.26%
Mr. Gordon A. Smith
Mr. Gordon A. Smith
Independent Director
Independent Director
765.00
--
Ms. Karen W. Katz
Ms. Karen W. Katz
Independent Director
Independent Director
590.00
--
Dr. David T. Feinberg, M.D.
Dr. David T. Feinberg, M.D.
Independent Director
Independent Director
441.00
--
Ms. Marcy S. Klevorn
Ms. Marcy S. Klevorn
Independent Director
Independent Director
436.00
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
20.63K
--
Mr. Kurt J. Hilzinger
Mr. Kurt J. Hilzinger
Independent Chairman of the Board
Independent Chairman of the Board
19.45K
--
Mr. Joseph Christopher (Joe) Ventura
Mr. Joseph Christopher (Joe) Ventura
Chief Legal Officer
Chief Legal Officer
17.32K
+48.83%
Dr. Vishal Agrawal, M.D.
Dr. Vishal Agrawal, M.D.
Chief Strategy and Corporate Development Officer
Chief Strategy and Corporate Development Officer
16.72K
+35.01%
Mr. Jorge S. Mesquita
Mr. Jorge S. Mesquita
Independent Director
Independent Director
2.58K
+55.96%
Mr. John W. Garratt
Mr. John W. Garratt
Independent Director
Independent Director
1.69K
+34.26%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Premiums
30.72B
94.84%
Service
1.40B
4.32%
Investment income
272.00M
0.84%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Premiums
30.72B
94.84%
Service
1.40B
4.32%
Investment income
272.00M
0.84%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.72%
Dodge & Cox
9.43%
BlackRock Institutional Trust Company, N.A.
5.24%
State Street Investment Management (US)
4.46%
Pzena Investment Management, LLC
3.35%
Other
65.80%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.72%
Dodge & Cox
9.43%
BlackRock Institutional Trust Company, N.A.
5.24%
State Street Investment Management (US)
4.46%
Pzena Investment Management, LLC
3.35%
Other
65.80%
Shareholder Types
Shareholders
Proportion
Investment Advisor
47.22%
Investment Advisor/Hedge Fund
36.65%
Hedge Fund
6.30%
Research Firm
2.54%
Bank and Trust
2.53%
Pension Fund
2.48%
Sovereign Wealth Fund
1.41%
Individual Investor
0.23%
Family Office
0.07%
Other
0.59%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
2206
122.13M
101.55%
-4.23M
2025Q2
2257
114.76M
95.42%
-19.25M
2025Q1
2321
116.64M
96.64%
-15.71M
2024Q4
2306
118.51M
98.19%
-7.58M
2024Q3
2271
114.45M
95.04%
-13.07M
2024Q2
2270
116.19M
96.50%
-5.74M
2024Q1
2237
112.35M
93.21%
-8.14M
2023Q4
2219
114.70M
93.84%
-10.54M
2023Q3
2136
116.47M
94.60%
-6.57M
2023Q2
2114
117.98M
95.21%
-8.26M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
14.14M
11.76%
+223.18K
+1.60%
Jun 30, 2025
Dodge & Cox
11.35M
9.44%
+597.71K
+5.56%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
6.28M
5.22%
-328.94K
-4.97%
Jun 30, 2025
State Street Investment Management (US)
5.38M
4.47%
+58.09K
+1.09%
Jun 30, 2025
Pzena Investment Management, LLC
4.08M
3.39%
+247.74K
+6.47%
Jun 30, 2025
Eagle Capital Management L.L.C.
3.95M
3.28%
+806.19K
+25.65%
Jun 30, 2025
JP Morgan Asset Management
2.07M
1.72%
+143.67K
+7.48%
Jun 30, 2025
Geode Capital Management, L.L.C.
3.13M
2.6%
+57.27K
+1.86%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.61M
2.17%
+518.01K
+24.72%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares U.S. Healthcare Providers ETF
4.36%
Eagle Capital Select Equity ETF
3.26%
American Customer Satisfaction ETF
2.4%
State Street SPDR S&P Health Care Services ETF
2.07%
Invesco S&P 500 Pure Value ETF
1.79%
Invesco S&P 500 Equal Weight Health Care ETF
1.66%
Alpha Architect US Quantitative Value ETF
1.65%
SRH US Quality GARP ETF
1.65%
iShares Large Cap Active ETF
1.57%
JPMorgan Active Value ETF
1.54%
View more
iShares U.S. Healthcare Providers ETF
Proportion4.36%
Eagle Capital Select Equity ETF
Proportion3.26%
American Customer Satisfaction ETF
Proportion2.4%
State Street SPDR S&P Health Care Services ETF
Proportion2.07%
Invesco S&P 500 Pure Value ETF
Proportion1.79%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.66%
Alpha Architect US Quantitative Value ETF
Proportion1.65%
SRH US Quality GARP ETF
Proportion1.65%
iShares Large Cap Active ETF
Proportion1.57%
JPMorgan Active Value ETF
Proportion1.54%
Dividend
A total of
1.93B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Oct 28, 2025
HUM.NB Final Cash Dividend of gross USD 0.885 paid on Jan 30, 2026 going ex on Dec 26, 2025
Dec 26, 2025
Jan 30, 2026
Dec 26, 2025
Feb 20, 2025
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 25, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 25, 2025
Mar 28, 2025
Oct 24, 2024
HUM.NB Final Cash Dividend of gross USD 0.885 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 15, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Oct 25, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 25, 2024
Sep 30, 2024
Apr 18, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Jul 26, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 26, 2024
Jun 28, 2024
Feb 15, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 26, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 26, 2024
Mar 27, 2024
Nov 02, 2023
HUM.NB Final Cash Dividend of gross USD 0.885 paid on Jan 26, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 26, 2024
Dec 28, 2023
Aug 17, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Oct 27, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 27, 2023
Sep 28, 2023
Apr 20, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Jul 28, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 28, 2023
Jun 29, 2023
Feb 16, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Humana Inc?
The top five shareholders of Humana Inc are:
The Vanguard Group, Inc. holds 14.14M shares, accounting for 11.76% of the total shares.
Dodge & Cox holds 11.35M shares, accounting for 9.44% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 6.28M shares, accounting for 5.22% of the total shares.
State Street Investment Management (US) holds 5.38M shares, accounting for 4.47% of the total shares.
Pzena Investment Management, LLC holds 4.08M shares, accounting for 3.39% of the total shares.
The Vanguard Group, Inc. holds 14.14M shares, accounting for 11.76% of the total shares.
Dodge & Cox holds 11.35M shares, accounting for 9.44% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 6.28M shares, accounting for 5.22% of the total shares.
State Street Investment Management (US) holds 5.38M shares, accounting for 4.47% of the total shares.
Pzena Investment Management, LLC holds 4.08M shares, accounting for 3.39% of the total shares.
What are the top three shareholder types of Humana Inc?
The top three shareholder types of Humana Inc are:
The Vanguard Group, Inc.
Dodge & Cox
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Dodge & Cox
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Humana Inc (HUM)?
As of 2025Q3, 2206 institutions hold shares of Humana Inc, with a combined market value of approximately 122.13M, accounting for 101.55% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 6.13%.
What is the biggest source of revenue for Humana Inc?
In FY2025Q2, the Premiums business generated the highest revenue for Humana Inc, amounting to 30.72B and accounting for 94.84% of total revenue.
